<DOC>
	<DOC>NCT01768325</DOC>
	<brief_summary>The purpose of this study is to evaluate a new EUS-guided biopsy needle (ProCore®) comparing it to conventional EUS-TCB needle (Quick-Core®) in the diagnosis of your suspicious disorder. This study needle (ProCore®) is a new EUS-guided biopsy needle and has been recently approved by the U.S. Food and Drug Administration (FDA) for use.</brief_summary>
	<brief_title>Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)</brief_title>
	<detailed_description>Primary Objective To compare the diagnostic accuracy of new EUS histology needle (19G, ProCore, Cook Medical Inc., Winston-Salem, NC) with the conventional histology needle (19G, Quick-Core, Cook Medical Inc., Winston-Salem, NC) Secondary Objective To compare - The number of needle passes requiring to acquire adequate specimen - Length of core tissue obtained - Diagnostic contribution of immunohistochemical staining - Rates of complications</detailed_description>
	<criteria>Inclusion criteria: Solid tumors ≥ 2 cm in size. Exclusion criteria: Thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ProCore Needle</keyword>
</DOC>